Patent Application Titled "Novel Immunogenic Peptides" Published Online (USPTO 20240342297).

A patent application titled "Novel Immunogenic Peptides" was published online by inventors from the US and Belgium. The application discusses peptides that combine MHC class II T cell epitopes with redox motif sequences to elicit CD4+ cytolytic T cells, potentially useful in treating allergies, immune disorders, tumors, transplant rejections, and viral infections. The peptides are designed to block immune responses by targeting antigen presenting cells, and the application outlines specific amino acid sequences and lengths for these peptides in various medical applications. [Extracted from the article]